Peptides and vitamin C: formulation, consistency and scientific evidence

Peptides and vitamin C can be present in the same cosmetic formulation, and several published clinical studies have evaluated products containing both types of ingredients. However, the fact that they were used together in the studied formulations does not mean that each peptide is compatible with every form of vitamin C. It also does not prove that two independently developed products can be mixed together without changing their chemical or physical properties, nor that the combination of peptides with vitamin C must lead to a synergistic effect.

An important obstacle is that neither the term „vitamin C” nor „peptide” refers to a single, uniform cosmetic ingredient. Vitamin C can mean L-ascorbic acid itself or one of its many chemically modified derivatives, differing in solubility, stability, formulation properties, and the method of delivery to the skin. Peptides are even more diverse and can include precisely defined synthetic sequences, chemically modified peptides, peptide complexes, and mixtures of fragments derived from proteins.

From a scientific perspective, a reliable assessment of compliance should therefore indicate a specific relationship between vitamin C, a specific peptide component, and the formulation in which both components were tested. General statements regarding entire categories of ingredients can be misleading, especially when results obtained for one molecule are extrapolated to materials with a different chemical structure.

In this article, we separate the chemistry of formulations from clinical results. We explain why pH, delivery system, packaging, and the chemical form of the ingredient are important, without converting individual experimental results into universal rules for skin care. We also discuss how to interpret clinical studies on ready-made formulations containing vitamin C and peptides, and the limits of the conclusions that can be drawn from them.

What form of vitamin C is contained in the formulation?

L-ascorbic acid and its derivatives are different compounds

L-ascorbic acid is the form of vitamin C most often discussed in the context of its biological functions in the skin. However, chemically modified derivatives of vitamin C are often used in cosmetics instead of unmodified L-ascorbic acid.

These derivatives can be developed to modify properties such as water or lipid solubility, chemical stability, retention in the formulation, or the method of delivery. Cosmetic formulations can therefore contain, among other things, ascorbic acid glucoside, sodium ascorbyl phosphate, magnesium ascorbyl phosphate, or fat-soluble ascorbyl esters.

Although all of these compounds are related to vitamin C, they should not be considered interchangeable substances.

The concentration given for one derivative of vitamin C may not correspond to the equivalent concentration of L-ascorbic acid in the skin. The final effect may be influenced by the identity of the molecule, the properties of the formulation, penetration, and the potential need for metabolic conversion after application.

This is particularly important when interpreting product labels.

These distinctions serve to provide a proper interpretation, rather than creating a ranking of ingredients from the best to the worst. The derivative vitamin C should be evaluated based on data regarding the specific molecule, and not automatically be considered better or worse just because it differs from free L-ascorbic acid.

Conversion and delivery require separate proofs of identity

Some derivatives of vitamin C may require chemical or enzymatic transformations before biological activity associated with L-ascorbic acid is observed. Therefore, the presence of a vitamin C derivative on the list of ingredients does not determine how effectively it penetrates the skin or how much active vitamin C becomes available.

One study evaluated a specific amphiphilic derivative of ascorbic acid in models of the living counterpart of human skin. The researchers analyzed the penetration, accumulation, and conversion and found that in the studied models, the derivative could release vitamin C. The observed metabolic pathway also differed depending on the model used.[1]

This is valuable evidence regarding this particular derivative under certain experimental conditions. However, this does not mean that all vitamin C derivatives release similar amounts of L-ascorbic acid during normal topical use.

Therefore, if a cosmetic product claims improved delivery of vitamin C, it is worth determining which molecule was actually measured; whether the study was conducted on cell cultures, reconstructed skin, isolated skin, or live participants; what the reference point was used as; and whether the original component, its metabolite, or both were measured.

The ingredient's name on the label alone does not answer these questions.

Results regarding delivery should also be separated from the apparent clinical effects. The detection of a derivative of vitamin C or its metabolite within a laboratory skin model provides information about penetration in that particular model. In itself, this does not prove an improvement in wrinkles, pigmentation, firmness, or other visible skin characteristics in humans.

Koniugat is not just a combination of two ingredients

Some experimental approaches go beyond placing vitamin C and peptides in a single formulation. Vitamin C-related structures can be chemically linked directly to the peptide, forming a new conjugate molecule.

In a 2009 laboratory study, a stabilized ascorbyl pentapeptide was analyzed. The authors described greater stability in aqueous environments compared to L-ascorbic acid and the effects associated with collagen in the experimental system used. [2]

It is crucial that the material under study was a specific ascorbyl-peptide conjugate. It was not simply a mixture of ordinary vitamin C serum with ordinary peptide serum.

Its stability and biological properties therefore concern the newly formed molecule.

This example shows why terminology matters. The combination in a single formulation, the chemical reaction, encapsulation, and the layering describe completely different chemical and formulation situations. The evidence should refer to the material actually being studied and the method of its preparation.

Why are pH and formulation important?

pH affects the chemical environment

pH describes the acidity or alkalinity of an appropriate aquatic environment. It can affect the ionization of molecules, the rate of reaction, solubility, and the interactions between components and their surroundings.

However, pH alone does not determine the full stability, delivery method, or clinical effectiveness of a cosmetic product.

A frequently cited study from 2001 analyzed the local delivery of L-ascorbic acid and selected its derivatives through the skin of pigs. In the experimental conditions used, increased delivery of L-ascorbic acid depended on the acidic environment of the formulation, and uptake was observed at pH below about 3.5.[3]

This result is scientifically significant, but its scope should be kept within proper limits. It concerned L-ascorbic acid in a specific experimental model. This was not a universal study of all vitamin C derivatives, all cosmetic carriers, or all combinations with peptides.

The correct requirement therefore is not: „Every product containing vitamin C must have a pH below 3.5”.

A more precise interpretation is that the pH influenced the delivery of L-ascorbic acid under the tested conditions, which shows how important the formulation properties can be for local delivery.

Other derivatives of vitamin C, carriers and delivery technologies require separate evaluation.

The stability of a peptide cannot be evaluated solely by the word „acid”

Another common simplification is the claim that an acidic environment must automatically destroy peptides.

Peptides differ significantly in their amino acid sequence, chemical modifications, molecular structure, and susceptibility to specific degradation pathways. Therefore, the effect of an acidic environment cannot be determined solely based on the substance’s classification as a peptide.

The time of exposure, temperature, water content, formulation environment, other ingredients, and storage conditions and packaging type are all important factors.

Peptide bonds can indeed undergo hydrolysis under certain chemical conditions. However, this general principle does not prove that a cosmetic peptide will quickly degrade every time it comes into contact with an acidic skincare product.

Proving such a process requires appropriate analytical data obtained under conditions representative of the formulation and exposure.

One should not assume the opposite either. The finding of one effective acidic formulation containing vitamin C and a peptide does not prove that all peptides are stable in an acidic environment.

Precision is therefore needed in both directions.

Chemical stability, physical properties and effects on the skin are different issues

Cosmetic formulations can be evaluated from several perspectives, which should not be combined into a single general concept of stability.

Chemical stability refers to whether the intended molecules remain chemically unchanged and whether their concentration remains at an appropriate level over time.

Physical stability includes, among other things, phase separation, precipitation, particle retention, viscosity, texture, and appearance.

Action on the skin, however, concerns what happens after application of the product, including the delivery of ingredients, tolerance, and measured biological or cosmetic effects.

These properties can change independently of each other.

The serum may still look normal even though the concentration of the active ingredient gradually decreases. In contrast, the visible change in texture does not indicate which molecule has undergone a chemical change or whether the active ingredient has degraded.

Therefore, properly selected analytical methods are needed to answer a specific question.

A 2023 liposomal formulation study showed an improvement in the photostability of L-ascorbic acid compared to the comparator formulations and analyzed its delivery in an ex vivo model of pig skin. [4]

This study shows an important principle: stability and delivery to the skin can be studied separately.

However, it did not evaluate the connection with peptides or the clinical advantage in humans. Therefore, it should not be taken as evidence that every encapsulated product with vitamin C is clinically more effective or that encapsulation automatically solves the problem of compatibility with peptides.

The packaging is part of the system under review

The packaging of a cosmetic product can affect the chemical environment in which its ingredients are located.

Contact with air, light, repeated opening, temperature, and method of use can affect stability. For this reason, packaging cannot always be analyzed independently of the formulation itself.

An opaque bottle, a small ampule, or a dispenser that restricts air access can be elements of a targeted strategy to increase stability. However, the mere use of advanced packaging does not prove that the ingredient maintains its declared concentration throughout the shelf life.

The most convincing data combine the specific formulation, packaging, storage conditions, and time with real analytical measurements.

The appearance of the product itself does not determine the remaining content of the active ingredient. The absence of color change does not rule out degradation, and the visible discoloration does not allow determining the exact amount of vitamin C lost.

This issue is part of a broader problem of formulation stability. More about the influence of temperature, humidity, packaging, and storage history can be read in the article Storage of peptides.

Products combined and products used separately

The ready combination is evaluated as one formulation

The finished product containing vitamin C and peptides is a deliberately designed formulation with a specific carrier, concentration of ingredients and production process.

The manufacturer can study the chemical behavior of the components, the physical stability, the microbiological quality, and the tolerance within this very system.

In published clinical studies, among other things, a low pH ampoule containing L-ascorbic acid along with peptide components derived from rice and lupine and hyaluronic acid was evaluated.[5]

This constitutes valid evidence that vitamin C and peptide components can coexist in an appropriately formulated and tested cosmetic formulation.

However, this is not a complete set of data regarding the stability of each component of the product and does not prove that the tested peptides can be replaced with any other peptides without affecting the properties of the formulation.

Therefore, the statement that vitamin C and peptide components can coexist in appropriately designed formulations is much more well-founded than the claim that vitamin C and peptides are always compatible.

The latter would require data on many different peptides, forms of vitamin C, concentrations, carriers, and environmental conditions.

Using two separate products does not replicate the finished formulation

Applying the product containing vitamin C and the peptide product separately does not replicate a professionally formulated serum containing both ingredients in a professional manner.

Each product has its own carrier, concentration of ingredients, pH and delivery system. When applied one on top of the other, they can interact on the skin surface in a way different from the formulation produced as a single product.

Physical mixing of the products before application further changes their relative proportions and the local formulation environment.

A clinical study of a single ready-to-use formulation with vitamin C and peptides does not therefore allow determining the order in which the two independent products should be applied. It also does not prove that a few-minute break between them improves the delivery of the ingredients or that their physical mixing preserves the original stability of both products.

The most reliable source remains the data and instructions regarding specific formulations.

If data is lacking regarding a specific connection or time between applications, it is more scientific to acknowledge this uncertainty than to create a precise but unproven rule.

A similar principle applies to the combination of peptides with other active cosmetic ingredients. We discuss this issue separately in the article. peptides and retinol.

Irritation is not evidence of chemical incompatibility

The skin discomfort after application does not prove that vitamin C reacted chemically with the peptide.

Irritation can result from many elements of the skincare routine. The acidic environment of a specific formulation may be significant, but fragrance substances, solvents, other active ingredients, frequency of use, previous disruption of the skin barrier, or existing dermatological problems can also have an impact.

The symptom itself does not allow for determining the responsible chemical mechanism.

The reverse rule also applies: the absence of discomfort does not prove chemical stability.

The product can be well tolerated, although its component is gradually degraded. Tolerance and chemical stability are two separate parameters that require different types of evidence.

In a large observational study of formulations containing vitamin C and peptides, generally favorable tolerability was described.[6] This provides useful information about the product and its users, but does not prove universal tolerance for all similar formulations.

In the case of particularly reactive skin, the entire formulation is of importance, not just the presence of the peptide itself. We discuss this issue in more detail in the article. peptides for sensitive and acne-prone skin.

Copper peptides require separate data

Peptides containing copper introduce additional chemical issues, because they are not equivalent to peptides that do not contain copper or to protein hydrolysates.

Questions regarding the coordination of metal, oxidation or other chemical interactions should be analyzed for the specific peptide–copper complex and the complete formulation.

Studies on peptides derived from rice, peptides from lupine, or palmitoilotripeptide-38 do not show that all copper peptides are compatible with vitamin C.

At the same time, these results do not justify the opposite, universal claim that every copper peptide must always be used separately from any product containing vitamin C.

Both claims go beyond the available evidence.

If the claim specifically concerns copper peptides and vitamin C, proper evaluation requires data regarding the compatibility and stability of the specific copper complex, the specific form of vitamin C, and the complete formulation. General observations regarding metals and vitamin C in other chemical systems do not replace the testing of the actual cosmetic product.

Evidence regarding the connections between vitamin C and peptides

There are controlled clinical trials, but they relate to specific formulations

A 2021 double-blind, randomized, placebo-controlled study involved 60 women aged 20–30 with signs of photoaging. Sunscreens and cosmetic formulations containing ascorbyl tetraisopalmitate and rice peptides were evaluated using skin imaging and bio-physical measurements. Improvements in skin hydration and other measured skin characteristics were noted.[7]

This is valuable controlled clinical evidence regarding a specific formulation program.

However, this does not mean that every serum containing vitamin C and peptides will provide the same results. The study included many ingredients, including sunscreen, which makes it difficult to attribute changes to a specific component.

The available information also does not support a statistical interaction confirming the synergy between vitamin C and peptides.

The specific form of vitamin C is also important. In the study, ascorbyl tetraisopalmitate was used, rather than ordinary L-ascorbic acid. When comparing the results with other studies, the actual chemical identity of this component must be kept in mind.

Short open-label studies provide observational data but weaker causal evidence

A publication on ampoules containing vitamin C and peptides described three studies. One analyzed a parameter related to cellular renewal compared to untreated skin, and two open-label studies evaluated wrinkles using clinical scales or instrumental methods. [5]

These studies provide information about the evaluated product, but their design does not allow the participation of peptide components to be isolated or to control all factors that could account for the difference between the pre- and post-application conditions.

In another open-label study, serum containing L-ascorbic acid, vitamin E, and palmitoylethrin-38 was evaluated over 56 days. During the study, instrumental measurements of skin surface area and participant assessments improved. [8]

Again, the result applies to the entire formulation.

Without a properly matched control product lacking palmitoylethrin-38, it is not possible to accurately determine which part of the observed improvement resulted from the presence of the peptide.

Objective measurement instruments can reduce some of the subjectivity, but they do not eliminate the need to use a proper reference point. Hydration, environmental conditions, other grooming elements, and natural changes over time can still affect the results.

Large observational studies increase the data set, but do not replace randomization

In an international observational study, the product in ampoules containing vitamin C and peptides was analyzed in a much larger population. The efficacy was evaluated in 1382 participants, and the safety in 1742. Within about a month, improvement was described along with generally favorable tolerability. Some participants used the product in conjunction with cosmetic procedures, which is important for interpreting the results.[6]

A large number of participants provide useful information about the experiences of people who use the formulation under study.

However, the size of the sample and the certainty regarding the causal relationship are two different characteristics of evidence.

Increasing the number of participants does not change an uncontrolled observational study into a randomized controlled trial. Without an appropriate control group, results can be influenced by concomitant caregiving, treatments, participants' expectations, and natural changes that occur over time.

The representativeness of the studied population is also important. If certain demographic groups or skin types predominate in it, the results should not be automatically applied to all populations.

Studies of individual components address other questions

Studies on vitamin C itself provide a useful background for understanding why combinations of vitamin C and peptides could be of scientific interest.

A placebo-controlled study of a topical vitamin C cream analyzed clinical and skin structure-related outcomes for approximately six months.[9] This provides data on topical vitamin C, but does not demonstrate an additional benefit resulting from the addition of peptides.

In another study involving humans, mRNA associated with collagen was measured after local administration of vitamin C compared to placebo. [10]

This is an important mechanistic result, but a change in the molecular marker is not equivalent to demonstrating a specific improvement in visible firmness or reduction of wrinkles.

Molecular changes, histological observations, instrumental measurements, and visible clinical results constitute related but distinct levels of evidence.

Studies of individual components can therefore provide a biological justification for investigating combinations, but they do not eliminate the need to evaluate the actual, ready-to-use formulation.

First, it is necessary to read what was actually measured

Research results are easier to interpret when the measured endpoint is clearly separated from the broader claim that someone would like to formulate based on it.

When interpreting the publication, the endpoint should be considered together with the comparator, the duration of the study, the number of withdrawals, the reporting of adverse events, the characteristics of the participants, and the source of funding.

It is also worth checking whether the commercial product in question currently meets the formulation studied in the publication. Products can be reformulated, and a similar name does not necessarily mean identical composition.

A scientific publication is therefore useful only to the extent that its experimental design actually supports the claim formulated on its basis.

Restrictions on the universal rules regarding compliance

Neither „never clash” nor „always agree” is based on evidence

Published studies on formulations combining vitamin C with peptides make it difficult to defend the categorical claim that these ingredients can never be effectively combined into a single product.

At the same time, the chemical diversity of both categories makes the opposite claim — that they are always compatible — equally unfounded.

The most justified proposal is conditional: specific components of vitamin C and specific peptides can be combined if the complete formulation has been properly designed and evaluated for this purpose.

Such wording reflects the actual scope of evidence without suggesting that every possible combination has already been examined.

The same principle applies to pH.

The result regarding unmodified L-ascorbic acid in one experimental vehicle does not specify the optimal formulation requirements for sodium ascorbyl phosphate, magnesium ascorbyl phosphate, ascorbyl glucoside, fat-soluble derivatives of vitamin C, or all other forms used in cosmetics.

Compliance does not mean effectiveness

Even if the formulation containing vitamin C and peptides is chemically and physically compatible, this does not automatically mean that it will produce a clinically significant effect.

The formulation can very well preserve the ingredients during storage, but it does not deliver them in sufficient quantities to the appropriate area of the skin.

It can also cause a statistically measurable change that is too small to translate into a noticeable cosmetic difference.

The opposite situation is also possible. A short-term clinical study may show beneficial cosmetic results, but it does not provide complete information about the long-term chemical stability, shelf life, or rare reactions.

Clinical studies and quality studies of formulations therefore complement each other. None of these types of data should be treated as the answer to all questions.

Claims about products become much more transparent when they accurately indicate what has been studied. Terms such as stable, delivered, absorbed, tolerated, and effective describe different properties and require different evidence.

No universal waiting time has been established between products

The analyzed studies do not specify a single number of minutes that should separate each peptide product from each product containing vitamin C.

They also do not establish a universal rule requiring the use of all combinations of vitamin C and peptides exclusively in the morning, evening, or at other specific times.

The application scheme used in the clinical study describes the way in which a specific intervention was evaluated. It should not automatically become a universal guideline for products containing other ingredients, concentrations, and delivery systems.

If data are lacking, it is more scientifically justified to admit that there is uncertainty and to use information about a specific product rather than to create a precise, but unproven, time interval.

Frequently asked questions

Can peptides and vitamin C be included in the same formulation?

Yes. In published clinical studies, finished formulations containing both peptide components and compounds related to vitamin C were evaluated. Some products contained L-ascorbic acid, while others contained specific derivatives of vitamin C.[5,7] These studies show that the coexistence of both categories of ingredients in a properly designed formulation is possible. However, they do not prove that any peptide can be replaced by another or that each form of vitamin C behaves identically. Each finished formulation requires data corresponding to its stability, tolerance, and claimed efficacy.

Can all forms of vitamin C be treated the same way?

No. L-ascorbic acid and vitamin C derivatives differ chemically and may have different properties regarding solubility, stability, delivery, and conversion. The study of a specific form of ascorbyl phosphate analyzed the penetration and conversion of this molecule specifically.[1] The results of these studies cannot be automatically applied to all other forms of vitamin C. Therefore, before comparing products or conducting studies, the exact identity of the component must be determined.

Does vitamin C always destroy peptides?

No. The available data do not support such a universal claim. In studies, the formulation containing low pH and vitamin C and peptide ingredients was evaluated, which shows that in appropriately designed products such a combination may be possible. [5] However, this does not mean that every peptide remains stable in every acidic product containing vitamin C. Compatibility should be evaluated for each peptide, specific form of vitamin C, and entire formulation.

Does every product containing vitamin C have to have a pH below 3.5?

No. The frequently cited pH value comes from specific experiments concerning the delivery of L-ascorbic acid through the skin of pigs. [3] The results show that the acidic environment influenced the delivery of L-ascorbic acid under these conditions. However, they do not establish a universal requirement for each vitamin C derivative and each delivery system.

Does a higher concentration of vitamin C mean better results?

Not necessarily. Concentration is only one of the elements of the formulation. The chemical form, carrier, and amount of the component retained during storage also matter; delivery to the skin and tolerance are also important. The percentage concentration of the vitamin C derivative should not be automatically interpreted as the same percentage of biologically available L-ascorbic acid. Delivery studies show how strongly these properties can depend on the specific molecule and formulation.[1,3]

Does layering two products in layers correspond to the use of a ready-made combined serum?

No. Two independently developed products do not replicate a single formulation containing both categories of ingredients. Their carriers, concentrations, and formulation environment are different, therefore their behavior after subsequent application may differ from that of the finished product. Studies of combined serums do not compare all possible methods of layered application. [8] The results should therefore remain attributed to the actually studied formulation.

Does mixing the two products reproduce the formulation from the clinical study?

No. The formulation evaluated in the clinical study contains specific components in controlled proportions and is produced and packaged as a single system. The combination of two independent cosmetics creates a different formulation. Studies of vitamin C delivery systems show that formulation properties can influence both the component’s retention and its penetration into skin models. [4]

Do the studies on combined products show synergy?

Not automatically. Proving synergy requires a design of the study that allows the effects of the individual components to be separated and to assess whether the combination yields a result exceeding the previously defined expectation. A controlled study of a multi-component care program can provide robust data about the entire program, but it does not prove that vitamin C and peptides were synergistic. [7]

Do the results of cell research prove a visible reduction in wrinkles?

No. The biological response observed in cell culture does not independently demonstrate penetration of the component through intact human skin or a visible improvement in humans. A study of the ascorbyl-pentapeptide conjugate showed, among other things, collagen-related activity under laboratory conditions, but it was not a controlled clinical study of wrinkles in humans. [2]

Is the combination of vitamin C and peptide just a simple mixture?

No. Coniugat is a chemically distinct material in which specific parts have been combined to form a different molecular structure. Therefore, the stabilized ascorbyl pentapeptide studied experimentally should not be treated as a counterpart to a conventional mixture of L-ascorbic acid and peptide. [2]

Does the lack of color change mean that the serum is stable?

No. Appearance and chemical composition are different properties. A product can retain its normal color even though the concentration of the active ingredient changes. Laboratory stability studies measure the corresponding compounds under specific conditions instead of relying solely on visual observation. [4] Similarly, discoloration does not allow for an accurate determination of which portion of the vitamin C has degraded.

Can cosmetics containing vitamin C and peptides replace sunscreen protection?

The reviewed studies do not show that vitamin C and peptide-containing skincare can replace sunscreen protection. One of the controlled studies on photoaging included sunscreen products as part of the evaluated intervention. [7] Therefore, this element cannot be removed from the reviewed program and it cannot be assumed that the results would have remained the same. Measurements of antioxidant activity, hydration, and skin appearance are also different from validated measurements of sunscreen protection.

Does every study on the combination of vitamin C and peptides also include copper peptides?

No. Studies on rice peptides, lupine peptides, or palmitoylethrin-38 do not automatically indicate the compatibility of copper-containing peptide complexes. [7,8] Copper peptides have their own chemical conditions and require data on the specific complex and formulation. The lack of such data neither justifies a universal ban on the combination of copper peptides with vitamin C nor ensures that any such combination is stable.

Does a large observational study prove a causal relationship?

No. A large group of participants can provide broader information about user experiences, but it does not replace an appropriate control group. An international study of a vial containing vitamin C and peptides included participants using various forms of cosmetic care and analyzed changes over time.[6] These observations are valuable, but uncontrolled factors may still influence the result.

Does the irritation indicate that vitamin C reacted with the peptide?

No. A mere irritation does not allow the identification of the chemical interaction between vitamin C and the peptide. The entire formulation, acidity, solvents, fragrance substances, other active ingredients, application regimen, other cosmetics, and the individual skin condition may be important factors. Similarly, good tolerability in the studied population does not guarantee that everyone will tolerate a different formulation. [6] Proofing chemical incompatibility requires analytical data.

Do collagen-related markers indicate a lasting increase in skin firmness?

No. Molecular measurement related to collagen biology is not equivalent to directly demonstrating the immediate improvement in visible firmness. In human vitamin C studies, molecular markers such as collagen-related mRNA were analyzed separately, which clearly shows the difference between mechanistic and clinical results.[10] The claim regarding visible firmness requires appropriate clinical measurements and a proper observation period.

Is there a required waiting time between products?

No universal time interval has been established. Clinical studies of ready-made formulations concern specific products and specific regimens of their use, not all possible combinations of independently developed cosmetics. [5] Therefore, based on them, it is not possible to establish a scientifically proven rule requiring a specific number of minutes between each peptide product and each vitamin C product.

Summary

Peptides and vitamin C can coexist in appropriately designed and tested cosmetic formulations. Published human studies provide direct examples of products containing both L-ascorbic acid and specific vitamin C derivatives in combination with various peptide ingredients. However, these results confirm the consistency of the specific formulations, rather than the universal principle regarding all possible combinations of vitamin C and peptides.

The determination of the exact form of vitamin C is crucial. L-ascorbic acid, ascorbic acid glucoside, sodium or magnesium ascorbyl phosphate, fat-soluble ascorbyl derivatives, and chemically linked vitamin C-peptide conjugates are not interchangeable materials. Evidence regarding one form should not be automatically transferred to another.

A peptide component requires the same level of precision. Defined synthetic peptides, modified peptides, copper peptides, peptide concentrates, and mixtures of peptides derived from proteins can significantly differ in their chemical behavior. The very word „peptide” therefore provides too little information to determine compatibility.

Additional complications arise from the formulation properties. pH can affect the behavior of molecules and the delivery of ingredients, but it is not a universal compatibility test. The composition of the carrier, water content, concentration, temperature, packaging, exposure to oxygen and light, and storage time can also be important factors.

Clinical evidence should also be interpreted in accordance with the design of the study. Controlled studies of finished formulations can provide valuable information about specific products, whereas open-label and observational studies are useful but provide less certainty regarding the causes of observed changes. In studies of multi-ingredient products, it is often not possible to determine which part of the improvement was specifically due to the peptide, vitamin C, or other component.

For the same reason, the coexistence of components should not be automatically described as synergy. The demonstration of improvement after the use of a product containing both components does not prove that they mutually enhance their effects. Synergy requires experimental comparisons designed specifically to demonstrate such an interaction.

Evidence regarding the finished combined product should not be transformed into universal instructions for independently formulated cosmetics either. Layering two products and physically mixing them together create a different formulation environment than that of professionally manufactured combined serums. The analyzed studies do not establish a single universal application sequence, pH value, or waiting time applicable to each product containing vitamin C and peptides.

The most reliable approach therefore consists of determining the exact molecule of vitamin C, the specific peptide component, the complete formulation, the design of the study, and the actually measured endpoint before interpreting claims regarding compliance or efficacy.

Peptides and vitamin C can be effectively combined in a single formulation, but chemical stability, physical compatibility, delivery to the skin, tolerance, and clinical efficacy remain separate properties requiring appropriate evidence.

Disclaimer

This article is for educational and scientific information purposes only. It explains the principles regarding cosmetic formulations and the limitations of published studies regarding vitamin C and peptide ingredients. It does not constitute an individual recommendation for skin care, medical advice, therapeutic guidance, or a formulation recipe.

Discussions of L-ascorbic acid, vitamin C derivatives, peptides, copper peptides, pH, layering, mixing, encapsulation, and formulation compatibility should not be interpreted as recommendations for combining specific commercial products or modifying finished cosmetics. Evidence for one formulation does not mean that another product containing similarly named ingredients will have the same chemical stability, delivery method, tolerance, or clinical efficacy.

The skin reaction may depend on the concentration of the ingredients, the vehicle of the formulation, the method of application, other products used, the current state of the skin, and the individual characteristics of the user. Therefore, the good tolerance observed in the published study does not mean universal suitability for every individual.

If the manufacturer of a finished cosmetic product provides specific recommendations regarding use, storage, or precautions, these apply to the specific formulation. Persistent or aggravated irritation, existing dermatological conditions, or issues requiring individual evaluation should be discussed with an appropriately qualified specialist, rather than being determined based on general information regarding the category of ingredients.

References

1. Shibayama, H., Hisama, M., Matsuda, S., & Ohtsuki, M. (2008). Permeation and metabolism of a novel ascorbic acid derivative, disodium isostearyl 2-O-L-ascorbyl phosphate, in human living skin equivalent models. Skin Pharmacology and Physiology, 21(4), 235–243. https://doi.org/10.1159/000139128
2. Choi, H. I., Park, J. I., Kim, H. J., Kim, D. W., & Kim, S. S. (2009). A novel L-ascorbic acid and peptide conjugate with increased stability and collagen biosynthesis. BMB Reports, 42(11), 743–746. https://doi.org/10.5483/bmbrep.2009.42.11.743
3. Pinnell, S. R., Yang, H., Omar, M., Monteiro-Riviere, N., DeBuys, H. V., Walker, L. C., Wang, Y., & Levine, M. (2001). Topical L-ascorbic acid: Percutaneous absorption studies. Dermatological Surgery, 27(2), 137–142. https://doi.org/10.1046/j.1524-4725.2001.00264.x
4. Ho, M. J., Park, D. W., & Kang, M. J. (2023). Design of novel tricaprylin-incorporated multi-layered liposomal system for skin delivery of ascorbic acid with improved chemical stability. Pharmaceuticals, 16(1), Article 121. https://doi.org/10.3390/ph16010121
5. Escobar, S., Valois, A., Nielsen, M., Closs, B., & Kerob, D. (2021). Effectiveness of a formulation containing peptides and vitamin C in treating signs of facial aging: Three clinical studies. International Journal of Cosmetic Science, 43(2), 131–135. https://doi.org/10.1111/ics.12665
6. Akulinina, I., Stefanaki, I., Pavlíčková, E., Maiolino, M., Hajduk, S., Sápy, M., Mertin, B., Rijo, H., Tekeli, Ö., Valois, A., Delva, C., & Kerob, D. (2022). Topical formulation containing peptides and vitamin C in ampoules improves skin aging signs: Results of a large, international, observational study. Journal of Cosmetic Dermatology, 21(9), 3910–3916. https://doi.org/10.1111/jocd.14733
7. Fossa Shirata, M. M., & Maia Campos, P. M. B. G. (2021). Sunscreens and cosmetic formulations containing ascorbyl tetraisopalmitate and rice peptides for the improvement of skin photoaging: A double-blind, randomized placebo-controlled clinical study. Photochemistry and Photobiology, 97(4), 805–815. https://doi.org/10.1111/php.13390
8. Lintner, K., Gerstein, F., & Solish, N. (2020). A serum containing vitamins C & E and a matrix-repair tripeptide reduces facial signs of aging as evidenced by Primos® analysis and frequently repeated auto-perception. Journal of Cosmetic Dermatology, 19(12), 3262–3269. https://doi.org/10.1111/jocd.13770
9. Humbert, P. G., Haftek, M., Creidi, P., Lapière, C., Nusgens, B., Richard, A., Schmitt, D., Rougier, A., & Zahouani, H. (2003). Topical ascorbic acid on photoaged skin. Clinical, topographical and ultrastructural evaluation: Double-blind study vs. placebo. Experimental Dermatology, 12(3), 237–244. https://doi.org/10.1034/j.1600-0625.2003.00008.x
10. Nusgens, B. V., Humbert, P., Rougier, A., Colige, A. C., Haftek, M., Lambert, C. A., Richard, A., Creidi, P., & Lapière, C. M. (2001). Topical application of vitamin C enhances the mRNA levels of collagens I and III, their processing enzymes and tissue inhibitor of matrix metalloproteinase 1 in the human dermis. Journal of Investigative Dermatology, 116(6), 853–859. https://doi.org/10.1046/j.0022-202x.2001.01362.x